Gotham Therapeutics

Gotham Therapeutics

Gotham Therapeutics

Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting the #epitranscriptomics machinery.
Raised
$54M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$54,000,000
Venture capital (Series A) - 2018
Celgene Versant Ventures S.R. One +2
Team Size
1–10
Employees
$54,000,000 Venture capital (Series A)
FinSMEs , PE HUB

Gotham Therapeutics Raises $54M in Series A Funding

Funding Health Science